1
Side effects were absent, and there was a trend of lymphedema reduction.
2
Neuropathic pain worsens with lymphedema, and treatment seems to improve the pain.
3
There is no additional carcinogenic factor except for chronic lymphedema in our case.
4
Earliest findings after lymphadenectomy and risk factors for lower leg lymphedema were investigated.
5
Three patients had congenital lymphedema, and one had congenital bilateral sensorineural hearing loss.
6
This follow-up analysis examines what, above and beyond lymphedema, contributes to cost differences.
7
Symptoms should be incorporated into screening and diagnostic criteria for lymphedema.
8
They frequently present in the elderly, and in patients with previous radiation or lymphedema.
9
The Kaplan-Meier method was used to estimate cumulative lymphedema incidence.
10
References to Charles for the treatment of leg lymphedema have proliferated since that time.
11
Hereditary lymphedema is a chronic swelling of limbs due to dysfunction of lymphatic vessels.
12
Services pertaining to lymphedema management were identified in 70% of cancer centers.
13
Conclusion: Lymphatic abnormalities precede lymphedema formation in BC patients.
14
This portion of the guidelines describes recommendations regarding the management of anthracycline-induced cardiotoxicity and lymphedema.
15
Hereditary lymphedema is a rare, lymphatic disorder resulting in the chronic swelling of the extremities.
16
Conclusion: Most patients referred to our lymphedema center were female with a history of cancer.
